Literature DB >> 2930075

Limitations of computed tomography in the assessment of emphysema.

R R Miller1, N L Müller, S Vedal, N J Morrison, C A Staples.   

Abstract

Thirty-eight patients undergoing lobectomy or pneumonectomy for carcinoma had preoperative computed tomography (CT) of the chest. Twenty-seven had both 1.5 mm and 10 mm collimation scans, and eleven had 10 mm collimation images only. These images were analyzed for the extent and severity of emphysema, and the analysis compared to the pathologic findings in the corresponding transverse slice of lung. The latter was graded by a modification of a panel of standards and by a grid system numerically expressing extent and severity. The grid system is theoretically superior to the panel of standards because it allows better quantitation of early emphysema and, contrary to the set of standards, is designed to analyze transverse CT images and corresponding pathologic slices. There was good correlation between the CT score and the pathologic score using the panel of standards (r = 0.81, p less than 0.001) but a lower correlation with the grid system (r = 0.70, p less than 0.001). The correlation improved slightly with 1.5 as compared to 10 mm collimation scans. Close comparison between the CT and grid scores showed that CT was sensitive in demonstrating early distal acinar and irregular emphysema. However, CT consistently underestimated the extent of centriacinar and panacinar emphysema because most lesions less than 0.5 cm in diameter were missed. We conclude that CT is insensitive in detecting the earliest lesions of emphysema.

Entities:  

Mesh:

Year:  1989        PMID: 2930075     DOI: 10.1164/ajrccm/139.4.980

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  24 in total

1.  Detection and quantification of pulmonary emphysema by computed tomography: a window of opportunity.

Authors:  M D Morgan
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

2.  Sliding thin slab, minimum intensity projection imaging for objective analysis of emphysema.

Authors:  Shiro Satoh; Shinichi Ohdama; Hitoshi Shibuya
Journal:  Radiat Med       Date:  2006-07

Review 3.  State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease.

Authors:  Eric A Hoffman; Brett A Simon; Geoffrey McLennan
Journal:  Proc Am Thorac Soc       Date:  2006-08

4.  Low-dose multislice CT and high-resolution CT assessment of pulmonary emphysema in public school teachers.

Authors:  Noriaki Horiuchi; Jiro Fujita; Ichizo Suemitsu; Yasuhiro Yamasaki; Futoshi Higa; Masao Tateyama
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

Review 5.  Functional imaging: CT and MRI.

Authors:  Edwin J R van Beek; Eric A Hoffman
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

6.  Automated classification of normal and pathologic pulmonary tissue by topological texture features extracted from multi-detector CT in 3D.

Authors:  H F Boehm; C Fink; U Attenberger; C Becker; J Behr; M Reiser
Journal:  Eur Radiol       Date:  2008-07-11       Impact factor: 5.315

7.  Quantitative chest tomography in COPD research: chairman's summary.

Authors:  Harvey O Coxson
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

Review 8.  Radiological imaging in the detection and differentiation of diffuse obstructive airway diseases.

Authors:  G A Lillington; N L Müller
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

Review 9.  Chronic obstructive pulmonary disease. 4: imaging the lungs in patients with chronic obstructive pulmonary disease.

Authors:  N L Müller; H Coxson
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

10.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD.

Authors:  R A O'Donnell; C Peebles; J A Ward; A Daraker; G Angco; P Broberg; S Pierrou; J Lund; S T Holgate; D E Davies; D J Delany; S J Wilson; R Djukanovic
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.